HER2-low status and response to neoadjuvant chemotherapy in HER2 negative early breast cancer
Luciana de Moura Leite, Marcelle Goldner Cesca, Monique Celeste Tavares, D. Maciel Santana, Erick Figueiredo Saldanha, Paula Tavares Guimarães, Daniella Dias Silva Sá, Maria Fernanda Evangelista Simões, Rafael Lima Viana, Francisca Giselle Rocha, Simone Klog Loose, Sinara Figueiredo Silva, Rafaela Pirolli, Camilla Albina Zanco Fogassa, Bruna Raphaeli Silva Mattos, Fernando Augusto Batista Campos, Solange Moraes Sanches, Vladmir Cláudio Cordeiro de Lima, Noam Falbel Pondé
Topics & Concepts
ImmunohistochemistryMedicineBreast cancerOncologyInternal medicineStage (stratigraphy)ChemotherapyTriple-negative breast cancerPathologicalTrastuzumabCancerNeoadjuvant therapyBiologyPaleontologyBreast Cancer Treatment StudiesHER2/EGFR in Cancer ResearchAdvanced Breast Cancer Therapies